|

It may just be early adopter tech types who log every step they take or calorie they burn using Fitbits, Nike Fuelbands, and other devices, but that hardly means they’re the only ones who track their health.
About 7 in 10 American adults told the Pew Internet & American Life Project that they track a health indicator like weight, diet, exercise or a symptom. But despite growing buzz around the “quantified self” movement and the explosion of gadgets and apps that help people measure and analyze everything from their activity and sleep patterns to blood glucose levels and other vital signs, just a small slice of health trackers rely on high tech devices.

You might be surprised to find out which companies lead pharmaceutical industry drug approvals. This infographic from DrugPatentWatch shows that Mylan, Aurobindo, and Apotex led 2012 drug approvals. What some readers may find surprising is the relative absence of branded pharmaceutical firms from this list.

New York Mayor Michael R. Bloomberg has pledged a $350 million gift to Johns Hopkins University to support interdisciplinary research and student financial aid, a commitment that will push his lifetime donations to his alma mater to more than $1 billion, the university announced Saturday.
Hopkins officials said they believe that Bloomberg will become the first person to reach the $1 billion level of giving to a single U.S. institution of higher education — an assertion that’s hard to verify because many donors give anonymously to universities. It is also difficult to compare the dollar value of modern donations to those in earlier eras.

TCM is proud to announce that Governor Martin O’Malley will be the featured speaker at TCM’s Leadership Dinner. The Governor will talk about Maryland’s knowledge economy, his legislative priorities and what’s in store for technology and biotechnology in 2013. Our annual Leadership Dinner in Annapolis brings together the region’s technology and life sciences sectors to network and learn about important policy issues. TCM will also share its legislative priorities for 2013.
We hope you can join us. Last year we had over 150 executives, TCM’s Board of Directors and 50 members from the Maryland General Assembly in attendance.


Scott Carmer (BHI Board Chair), Jerry Parrott, and Rich Bendis (BHI CEO)
On January 24th, 2013 BioHealth Innovation, Inc. (BHI) recognized Jerry Parrott, formerly with Human Genome Sciences, for his contributions as a BHI Founding Board member. He served on the board from 2011 to 2013 and will continue to remain active on BHI’s Commercial Relevance Advisory Board (CRAB). We thank Jerry for his service and look forward to a long lasting relationship.

NHLBI Funding and Research Opportunities
The following funding opportunities from the NHLBI or other components of the National Institutes of Health, might be of interest:
NIH Guide Notices:
- NOT-OD-13-025: Notice Announcing FAQ Page and Pre-Application Webinar for RFA-OD-12-007 “NIH Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P30)”
- NOT-HL-12-165: Request for Information – Production Assistance for Cellular Therapies (PACT)
- NOT-HL-13-166: Request for Information (RFI) for High-Priority Research Topics for Sedentary Behavior
Please note that most links to RFAs, PAs, and Guide Notices will take you to the NIH Web site. RFPs will take you to FedBizOpps. Links to RFPs will not work past their proposal receipt date. Archived versions of RFPs posted on FedBizOpps can be found on the FedBizOpps site using the FedBizOpps search function. Under “Document to Search,” select Archived Documents.

Maryland is looking to build on the success of a biotechnology tax credit to bolster another industry here — cyber security.
Gov. Martin O’Malley proposed in his fiscal 2014 budget a new cyber security tax credit that would set aside $3 million to encourage cyber security companies to expand or set up shop in Maryland.

Venture capital firm SR One has launched “OneStart,” its first business plan competition, in association with Oxbridge Biotech Roundtable and Stevenage Bioscience Catalyst. OneStart is designed to inspire and encourage its participants to become the next generation of European bio- entrepreneurs. The £100,000 winner-takes-all prize will be the largest of its kind in the world. Uniquely, OneStart will actively connect individuals from a range of institutions and backgrounds.
OneStart is open to aspiring life science entrepreneurs age 35 and younger who are studying or working in Europe. The competition will be run in stages and cover four tracks: drug discovery, medical devices, diagnostics and health information technology. The competition will team up those who have developed a technology or idea, such as academics, with individuals who have complementary backgrounds and skills, e.g. business school students, or young professionals from pharma or biotech.